Intra-articular steroid injection for knee osteoarthritis in non diabetics and controlled diabetics.
Not Applicable
- Conditions
- Health Condition 1: M179- Osteoarthritis of knee, unspecified
- Registration Number
- CTRI/2024/08/071790
- Lead Sponsor
- All India Institute of Medical Sciences (AIIMS), Guwahati
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Individuals (non-diabetics and controlled diabetics) 45 years of age or older with unilateral or bilateral symptomatic knee pain (NRS =4/10) on most days for the past more than 1 month and radiologically (X-ray) confirmed knee OA with Kellgren-Lawrence (KL) radiographic severity grade 2–3
Exclusion Criteria
Refusal to consent.
Patients (with or without diabetes) having HbA1c = 7% at baseline
IASI in the past 3 months
History of any systemic inflammatory arthritis
History of trauma, surgery or infection in the affected knee joint
Overlying skin and soft tissue infection
Uncontrolled bleeding diathesis
Known case of cancer
Clinically significant cognitive impairment
Known allergy to triamcinolone acetonide or lignocaine
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the responsiveness of intra articular steroid injections in knee osteoarthritic patients.Timepoint: baseline and at 2 weeks and 4 weeks.
- Secondary Outcome Measures
Name Time Method Observe CRP levels in each groupTimepoint: At 2 weeks and 4 weeks;Observe local or systemic complicationsTimepoint: At 2 weeks and 4 weeks;Quantify dose of rescue analgesicTimepoint: At 2 weeks and 4 weeks